A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

This study examined the pathological complete response (pCR) rate and safety of sequential gemcitabine-based combinations in breast cancer. We also examined gene expression profiles from tumour biopsies to identify biomarkers predictive of response. Indian women with large or locally advanced breast...

Full description

Saved in:
Bibliographic Details
Main Authors: Julka, P K, Chacko, R T, Nag, S, Parshad, R, Nair, A, Oh, D S, Hu, Z, Koppiker, C B, Nair, S, Dawar, R, Dhindsa, N, Miller, I D, Ma, D, Lin, B, Awasthy, B, Perou, C M
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2008
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361717/
https://ncbi.nlm.nih.gov/pubmed/18382427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604322
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items